GlassScriptPhysician profile
David Y Kim
NPI 1790341691
$3,567.87
in general payments reported to CMS, 2019-2025
34 companies · $645 in 2025
The $645 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,042 · 2022: $326 · 2023: $270 · 2024: $285 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.71 | 2021-2025 | |
| Novo Nordisk INC | $469.14 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $259.22 | 2021 | |
| Pfizer INC. | $239.41 | 2021-2025 | |
| Eisai INC. | $230.56 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $194.98 | 2021-2022 | |
| Amarin Pharma, INC. | $187.60 | 2021-2022 | |
| Trisalus Life Sciences, INC. | $169.22 | 2023-2024 | Trinav Infusion System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.72 | 2021-2022 | |
| Amgen INC. | $112.23 | 2021-2022 | |
| Astellas Pharma US INC | $99.88 | 2021 | |
| Boston Scientific Corporation | $96.39 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Janssen Biotech, INC. | $76.66 | 2025 | |
| Neos Therapeutics, LP | $74.11 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $71.88 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $71.87 | 2021 | |
| Medtronic, INC. | $71.53 | 2022-2025 | Kyphon Express II Kyphopak Tray, Interstim |
| Esperion Therapeutics, INC. | $50.98 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.69 | 2021 | |
| Terumo Medical Corporation | $30.74 | 2022 | |
| Merck Sharp & Dohme LLC | $30.55 | 2021 | |
| Sirtex Medical INC | $27.81 | 2023 | Sir-Spheres Microspheres |
| Lundbeck LLC | $27.62 | 2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $27.54 | 2021 | |
| B. Braun Interventional Systems INC. | $25.94 | 2023 | No Marketed Product Name |
| Axsome Therapeutics, INC. | $24.53 | 2025 | Symbravo |
| Bayer Healthcare Pharmaceuticals INC. | $24.09 | 2025 | |
| Biogen, INC. | $16.80 | 2021 | |
| Siemens Medical Solutions USA, INC. | $14.33 | 2023 | Oncozene |
| Bausch Health US, LLC | $14.21 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.64 | 2021 | |
| Glaxosmithkline, LLC. | $12.29 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.